Abstract:Schizophrenia is a chronic debilitating psychiatric disorder affecting as many as 1% of the population worldwide. Unfortunately, its etiology and pathophysiology are poorly defined. Previous studies have shown that neuronal injury and microglia activation were observed in the schizophrenic patients. The present study aims to evaluate the role of neurons and microglia in ketamine-induced experimental schizophrenic model to further understand its pathophysiology. Firstly, ketamine was used to simulate the behavior abnormalities associated with schizophrenia. The effects of ketamine on mouse locomotor activity, Y-maze task, novel object recognition, and forced swimming test were studied. The results showed that ketamine (25, 50, and 100mg/kg i.p.) administered acutely or repeatedly (for 7days) can increase the locomotor number significantly. In Y-maze task, ketamine (25, 50, and 100mg/kg) impaired spontaneous alternation after both acute and repeated treatments. In novel object recognition test, acute or chronic ketamine treatment showed no significant effect on mouse exploratory preference behavior. In forced swimming test, repeated treatment of ketamine (100mg/kg) enhanced the immobility duration. Secondly, immunohistochemical method was used to study the changes of neurons and microglia. The results showed that acute treatment of ketamine (100mg/kg) had no effect on neurons in the prefrontal cortex or hippocampus (1, 3, 5, and 7days after the treatment). In contrast, repeated treatment of ketamine caused neuronal impairment in mouse hippocampus (3rd day, 5th day and 7th day after the final administration). The results of immunohistochemistry demonstrated that microglia in the prefrontal cortex and hippocampus were not affected after acute or repeated administration of ketamine. Finally, the neuronal impairment caused by repeated administration of ketamine was further investigated from the oxidative stress aspects. The results showed that repeated administration of ketamine increased nitric oxide (NO) and nitric oxide synthase (NOS) in prefrontal cortex, hippocampus and serum, while decreased SOD in hippocampus and serum. In summary, chronic ketamine treatment to mice successfully mimics the core behavioral deficits in schizophrenia. It is demonstrated for the first time that neuronal injury was associated with the chronic ketamine-induced experimental schizophrenic model, while microglial cells may play little role in this model. Oxidative stress may contribute to the significant neuronal injury in mouse brain induced by chronic ketamine treatment.

Integrin-dependent microgliosis mediates ketamine-induced neuronal apoptosis during postnatal rat retinal development.

Laminin degradation by matrix metalloproteinase 9 promotes ketamine-induced neuronal apoptosis in the early developing rat retina

Kainic Acid-Activated Microglia Mediate Increased Excitability of Rat Hippocampal Neurons in vitro and in vivo: Crucial Role of Interleukin-1beta

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Induces Microglial Nitric Oxide Production and Subsequent Rat Primary Cortical Neuron Apoptosis Through P38/jnk MAPK Pathway.

IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.

Repeated Administration of Ketamine Can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment Via the ROS/HIF-1α Pathway in Developing Rats

Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.

Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.

NMDA-receptor blockade enhances cell apoptosis in the developing retina of the postnatal rat

Ketamine Exacerbates Cortical Neuroapoptosis under Hyperoxic Conditions by Upregulating Expression of the N-methyl-D-aspartate Receptor Subunit NR1 in the Developing Rat Brain

Microglia mediate non-cell-autonomous cell death of retinal ganglion cells

Nicotinic Acetylcholine Receptors are Associated with Ketamine-induced Neuronal Apoptosis in the Developing Rat Retina.

Neuron-Glia Crosstalk Plays a Major Role in the Neurotoxic Effects of Ketamine via Extracellular Vesicles

Role of NF-κB in ketamine-induced apoptosis in rat cortical neurons in vitro

Effects of Ketamine on Glutamate-Induced Apoptosis of Cultured Rat Spinal Dorsal Horn Neurons and Astrocytes

NLRP3 inflammasome in NMDA-induced retinal excitotoxicity

Ketamine Induces Neuronal Apoptosis and Cognitive Disorder Via Mir-199A-5p/hif-1α in Neonatal Rats

Microglia activation in the hippocampus mediates retinal degeneration-induced depressive-like behaviors via the NLRP3/IL-1β pathway

Effects of ketamine on the neurons apoptosis and NMDAR-2B expression in neonatal rats hippocampal CA3 area

Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice

Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice.